Context Therapeutics announced it raised $100 Million in an initial filing from an offering of $100 Million
Context Therapeutics announced it raised $100 Million in an initial filing from an offering of $100 Million
05/16/24, 8:06 PM
Location
philadelphiaMoney raised
$100 million
Industry
healthcare
Company Info
Location
2001 market street
philadelphia, pennsylvania, united states
Additional Info
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors. Context is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, currently in preclinical development.